CAR-T
Most Read
New data on CRISPR Therapeutics’ off-the-shelf CAR-T cancer therapy shows more remissions, no major safety issues
Additional blood cancer responses seen with Allogene’s off-the-shelf CAR-T cells, updated study shows
Vindicated. New J&J CAR-T myeloma data confirm strong efficacy, ease doubts raised by Chinese version
New data show Bluebird, Bristol CAR-T drug could be pioneering myeloma therapy. Competitors may be close behind
Cellectis off-the-shelf CAR-T therapy grounded following patient’s toxic death
Insight into exhausted immune cells could open new doors for cancer therapy
